SAKAR HEALTHCARE
|
The Current P/E Ratio of SAKAR HEALTHCARE is 59.42.
Share Price | ₹341.6 | May 06,2024 |
Market Cap | ₹741.2 Cr | |
Earnings-TTM | ₹12.5 Cr | TTM-Consolidated Results |
Price/Earnings | 59.42x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹741.2 Cr] as on May 06,2024
(/) Earnings [ ₹12.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 59.42x ]
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 59.42 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2023 to Mar2020 averaged 17.37x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2023 at 29.94x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SAKAR HEALTHCARE | 12.47 | 59.42 | 741.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.79 | 367,026.0 |
CIPLA LTD | 3,744.03 | 30.70 | 114,925.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 20.18 | 105,109.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 34.78 | 102,736.0 |
DIVIS LABORATORIES LTD | 1,382.97 | 76.02 | 105,128.0 |
MANKIND PHARMA LTD | 1,743.30 | 52.48 | 91,490.4 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 61.52 | 91,906.5 |
LUPIN LTD | 1,809.74 | 42.30 | 76,554.6 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.53 | 68,144.7 |
ABBOTT INDIA LTD | 1,145.58 | 47.79 | 54,743.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.18x |
Max industry PE | 76.02x |
Median industry PE | 42.30x |
Average industry PE | 44.59x |
You may also like the below Video Courses